Evidence map›Paper›PMID 29631608›Full record

ArticleStem cell research & therapy2018

Transcriptional activator DOT1L putatively regulates human embryonic stem cell differentiation into the cardiac lineage.

Varsha Pursani, Deepa Bhartiya, Vivek Tanavde, Mohsin Bashir, Prabha Sampath

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Varsha PursaniStem Cell Biology Department, ICMR-National Institute for Research in Reproductive Health, J.M. Street, Parel, Mumbai, Maharashtra, 400 012, India.
Deepa BhartiyaStem Cell Biology Department, ICMR-National Institute for Research in Reproductive Health, J.M. Street, Parel, Mumbai, Maharashtra, 400 012, India. deepa.bhartiya@yahoo.in.
Vivek TanavdeDivision of Biological & Life Sciences, School of Arts & Sciences, Ahmedabad University, Ahmedabad, 380009, India.
Mohsin BashirDivision of Translational Control of Disease, A* Star-Institute of Medical Biology, Singapore, 138648, Singapore.
Prabha SampathDivision of Translational Control of Disease, A* Star-Institute of Medical Biology, Singapore, 138648, Singapore.
Institute of Medical Biology · SGNational Institute for Research in Reproductive Health · INAhmedabad University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommitment of pluripotent stem cells into differentiated cells and associated gene expression necessitate specific epigenetic mechanisms that modify the DNA and corresponding histone proteins to render the chromatin in an open or closed state. This in turn dictates the associated genetic machinery, including transcription factors, acknowledging the cellular signals provided. Activating histone methyltransferases represent crucial enzymes in the epigenetic machinery that cause transcription initiation by delivering the methyl mark on histone proteins. A number of studies have evidenced the vital role of one such histone modifier, DOT1L, in transcriptional regulation. Involvement of DOT1L in differentiating pluripotent human embryonic stem (hES) cells into the cardiac lineage has not yet been investigated.

methodsThe study was conducted on in-house derived (KIND1) and commercially available (HES3) human embryonic stem cell lines. Chromatin immunoprecipitation (ChIP) was performed followed by sequencing to uncover the cardiac genes harboring the DOT1L specific mark H3K79me2. Following this, dual immunofluorescence was employed to show the DOT1L co-occupancy along with the cardiac progenitor specific marker. DOT1L was knocked down by siRNA to further confirm its role during cardiac differentiation.

resultsChIP sequencing revealed a significant number of peaks characterizing H3K79me2 occupancy in the proximity of the transcription start site. This included genes like MYOF, NR2F2, NKX2.5, and HAND1 in cardiac progenitors and cardiomyocytes, and POU5F1 and NANOG in pluripotent hES cells. Consistent with this observation, we also show that DOT1L co-localizes with the master cardiac transcription factor NKX2.5, suggesting its direct involvement during gene activation. Knockdown of DOT1L did not alter the pluripotency of hES cells, but it led to the disruption of cardiac differentiation observed morphologically as well as at transcript and protein levels.

conclusionsCollectively, our data suggests the crucial role of H3K79me2 methyltransferase DOT1L for activation of NKX2.5 during the cardiac differentiation of hES cells.

Indexed as

Cell DifferentiationBasic Helix-Loop-Helix ProteinsCalcium-Binding ProteinsCell LineCell LineageCells, CulturedHistone-Lysine N-MethyltransferaseHomeobox Protein Nkx-2.5Human Embryonic Stem CellsHumansMembrane ProteinsMethyltransferasesMuscle ProteinsMyocytes, CardiacNF-E2-Related Factor 2Basic Helix-Loop-Helix ProteinsCalcium-Binding ProteinsDOT1L protein, humanhelix-loop-helix protein, eHANDHistone-Lysine N-MethyltransferaseHomeobox Protein Nkx-2.5Membrane ProteinsMethyltransferasesMuscle ProteinsMYOF protein, humanNFE2L2 protein, humanNF-E2-Related Factor 2NKX2-5 protein, humanCardiac differentiationDOT1LEpigeneticsGene expressionHistone methyltransferaseHuman embryonic stem cells

Identifiers

PMID29631608
PMCPMC5891944
OpenAlexW2798147139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.